The Team

Wasim Munawar

Chief Executive Officer

Marketing and Sales executive for 25 years in breast biopsy at Becton Dickinson (BD), Neothermia/Intact Medical (acquired by Medtronic) and US Surgical (acquired by Medtronic)

Successfully launched 16 medical products in domestic & global markets

Expertise in market strategy, sales leadership, and product launch & development

Proven track record in building teams, strategic partnerships, and innovation in women’s health

Philip E. Eggers

Chairman of the Board and Chief Technology Officer

Founder of 7 medical device companies including ArthroCare that became a public company in 1996 with sales growing to $400 million/year before acquisition by Smith & Nephew in 2014

49 years medical device development experience including creation of intellectual property, product design, prototype construction, bench testing, animal studies, clinicals, commercialization

Inventor or co-inventor of 202 U.S. patents plus 9 U.S. and foreign patents pending

Andrew R. Eggers

VP Product Development

31 years of medical device development experience including product design, prototype construction, bench-top testing, animal studies, clinical trials, contract manufacturing

24 years of experience in the development of percutaneous excision of en bloc tissue specimens for biopsy and lumpectomy

Co-inventor of 30 U.S. patents plus 9 U.S. and foreign patents pending

Mark Mayerchak

VP Engineering

36 years of electrical engineering experience in development and manufacture of medical device controller systems and monitors

21 years of experience in the development of percutaneous excision of en bloc tissue specimens for biopsy and lumpectomy

Scott Huntley

VP Clinical and Regulatory

32 years of experience in product development, marketing and sales in the medical device industry

24 years of experience in women’s health, including the development of percutaneous excision of en bloc tissue specimens for biopsy and lumpectomy

Join Us in Revolutionizing Breast Cancer Care.

Learn more about investment opportunities.

Scroll to Top